Kowa Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KOWA PHARMS, and what generic alternatives to KOWA PHARMS drugs are available?
KOWA PHARMS has one approved drug.
There are seven US patents protecting KOWA PHARMS drugs.
There are ninety-one patent family members on KOWA PHARMS drugs in thirty-five countries and one supplementary protection certificate in one country.
Summary for Kowa Pharms
| International Patents: | 91 |
| US Patents: | 7 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Kowa Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 8,846,744 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 9,012,440 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 10,238,668 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 8,598,152 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 11,478,488 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 10,245,276 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Kowa Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| New Zealand | 603457 | ⤷ Subscribe |
| Portugal | 2575778 | ⤷ Subscribe |
| San Marino | T201300048 | ⤷ Subscribe |
| Russian Federation | 2012120088 | ⤷ Subscribe |
| Slovenia | 2349238 | ⤷ Subscribe |
| China | 102186465 | ⤷ Subscribe |
| Australia | 2010306168 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Kowa Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0731795 | 10075033 | Germany | ⤷ Subscribe | PRODUCT NAME: CELECOXIB; NAT. REGISTRATION NO/DATE: 48802.00.00 20000518; FIRST REGISTRATION: SE 14838 19991203 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
